Novanta (NASDAQ:NOVT) Issues Q3 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) issued an update on its third quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.950-1.000 for the period, compared to the consensus earnings per share estimate of 0.940. The company issued revenue guidance of $300.0 million-$304.0 million, compared to the consensus revenue estimate of $263.1 million. Novanta also updated its FY 2026 guidance to 3.680-3.740 EPS.

Novanta Stock Down 4.0%

Shares of Novanta stock traded down $6.37 during trading hours on Wednesday, reaching $153.12. 548,040 shares of the company’s stock were exchanged, compared to its average volume of 466,732. The stock has a market cap of $5.78 billion, a P/E ratio of 110.96 and a beta of 1.68. Novanta has a fifty-two week low of $98.27 and a fifty-two week high of $171.85. The company has a 50 day moving average of $154.02 and a two-hundred day moving average of $141.07. The company has a current ratio of 3.56, a quick ratio of 2.69 and a debt-to-equity ratio of 0.15.

Novanta (NASDAQ:NOVT) last announced its earnings results on Wednesday, August 5th. The technology company reported $0.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.06. The company had revenue of $265.81 million during the quarter, compared to analysts’ expectations of $262.30 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. On average, sell-side analysts forecast that Novanta will post 3.59 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on NOVT shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a research note on Wednesday, July 15th. Wall Street Zen lowered Novanta from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Robert W. Baird set a $180.00 target price on shares of Novanta in a research note on Tuesday, June 9th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $180.00.

Insiders Place Their Bets

In related news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the completion of the transaction, the chief executive officer owned 42,761 shares of the company’s stock, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Novanta

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quadrant Capital Group LLC raised its stake in Novanta by 1,550.5% during the fourth quarter. Quadrant Capital Group LLC now owns 3,598 shares of the technology company’s stock worth $428,000 after acquiring an additional 3,380 shares during the period. Van ECK Associates Corp increased its holdings in shares of Novanta by 113.3% in the 4th quarter. Van ECK Associates Corp now owns 3,471 shares of the technology company’s stock worth $413,000 after acquiring an additional 1,844 shares during the period. Nicolet Advisory Services LLC boosted its stake in Novanta by 7.1% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,046 shares of the technology company’s stock valued at $409,000 after purchasing an additional 269 shares during the period. Toronto Dominion Bank raised its holdings in shares of Novanta by 32.7% during the fourth quarter. Toronto Dominion Bank now owns 3,382 shares of the technology company’s stock valued at $402,000 after buying an additional 834 shares during the last quarter. Finally, Laurion Capital Management LP bought a new position in Novanta in the 4th quarter worth approximately $384,000. 98.35% of the stock is owned by hedge funds and other institutional investors.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.